Loading…
CVS Health Corporation is projected to rise to $140.44 by 2027, a +35% move from its current price of $104.15. CVS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $102.81 | $104.21 | $105.64 | +0.06% |
| Jul 15 | $102.29 | $104.28 | $106.30 | +0.12% |
| Jul 16 | $101.92 | $104.34 | $106.82 | +0.18% |
| Jul 17 | $101.61 | $104.40 | $107.27 | +0.24% |
| Jul 18 | $101.34 | $104.47 | $107.68 | +0.30% |
| Jul 19 | $101.11 | $104.53 | $108.06 | +0.36% |
| Jul 20 | $100.90 | $104.59 | $108.41 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $100.90 | $104.59 | $108.41 | +0.42% |
| Week 2 | $99.84 | $105.03 | $110.50 | +0.85% |
| Week 3 | $99.12 | $105.48 | $112.24 | +1.28% |
| Week 4 | $98.59 | $105.93 | $113.81 | +1.71% |
| Week 5 | $98.17 | $106.38 | $115.26 | +2.14% |
| Week 6 | $97.84 | $106.83 | $116.64 | +2.57% |
| Week 7 | $97.56 | $107.28 | $117.97 | +3.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CVS Health Corporation provides health solutions in the United States through three segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services.
The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.
The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Health Corporation, trading under the symbol CVS, has a current price of $100.48 and a market cap of $128.21B, ranking 115. The asset is positioned in the Healthcare sector and carries a bullish technical tone adjacent to a $100.48 resistance level with a $80.69–$100.48 support band referenced by its current chart structure. The multi-year forecast envisions a path from a 2026 average near $100.48 to substantially higher levels by 2030 ($201.73 avg), 2040 ($711.30 avg), and 2050 ($1,303.15 avg), with bullish sentiment indicated across several future years.
A major floor 32.7% below — a decisive break under it would weaken the trend.
The nearest floor, 14.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.6% away) — a breakout level to watch.
A major ceiling 10.2% above — clearing it would confirm fresh momentum.
Key CVS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CVS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $103.57 | Buy | $103.77 | Buy |
| MA 10 | $103.87 | Buy | $103.41 | Buy |
| MA 20 | $102.47 | Buy | $101.78 | Buy |
| MA 50 | $95.92 | Buy | $96.04 | Buy |
| MA 100 | $86.05 | Buy | $89.82 | Buy |
| MA 200 | $82.30 | Buy | $83.34 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.53 | Neutral |
| Stoch RSI (14) | 22.36 | Neutral |
| CCI (20) | 67.39 | Neutral |
| Williams %R (14) | -18.80 | Info |
| MACD (12,26,9) | -0.39 | Sell |
| ROC (12) | 2.54 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 81.20 | Sell |
| TRIX (15) | 0.44 | Buy |
| Awesome (5,34) | 4.83 | Buy |
| Ultimate (7,14,28) | 59.71 | Neutral |
| Momentum (10) | -0.51 | Sell |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 103.70 | Buy |
| ADX (14) | 31.00 | Buy |
| ATR (14) | 1.25 | Info |
The 30-day technical picture is bullish, with RSI(14) at 70 indicating strength near overbought territory. The stock trades above the SMA50 of $86.25 and above the SMA200 of $79.53, suggesting a positive intermediate-term trend. Support is cited at $80.69 and resistance at $100.48, with the 30-day range spanning from $90.29 to $111.82.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $70.08 | $104.15 | $140.63 | 0% | Neutral | |
| $115.02 | $140.44 | $179.27 | +35% | Bullish | |
| $129.13 | $160.63 | $210.59 | +54% | Bullish | |
| $147.00 | $185.67 | $248.61 | +78% | Bullish | |
| $157.50 | $201.63 | $274.84 | +94% | Bullish | |
| $178.27 | $231.00 | $319.85 | +122% | Bullish | |
| $223.31 | $292.64 | $410.97 | +181% | Bullish | |
| $250.38 | $331.56 | $471.66 | +218% | Bullish | |
| $280.28 | $374.86 | $539.62 | +260% | Bullish | |
| $314.52 | $424.63 | $618.08 | +308% | Bullish | |
| $508.27 | $715.71 | $1,091.72 | +587% | Bullish | |
| $889.93 | $1,343.98 | $2,197.52 | +11.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $70.08 | $104.15 | $125.92 | +0.00% |
| August 2026 | $94.09 | $110.13 | $131.70 | +5.74% |
| September 2026 | $93.57 | $110.05 | $132.62 | -0.08% |
| October 2026 | $92.83 | $109.62 | $132.99 | -0.39% |
| November 2026 | $94.90 | $112.47 | $137.19 | +2.59% |
| December 2026 | $96.48 | $114.70 | $140.63 | +1.99% |
Click any year to see its month-by-month CVS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CVS is projected to trade between $70.08 and $140.63, averaging $104.15 — a potential gain of 0% from today's $104.15. A consolidation phase looks the most probable path here.
CVS Health Corporation's 2027 outlook centres on $140.44, within a $115.02 to $179.27 range. That is up +35% on the projected 2026 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2028, CVS could reach as high as $210.59, with a base case around $160.63 and support toward $129.13 — roughly +54% from $104.15. Buyers look set to stay in control over this stretch.
Expect CVS to range from $147.00 to $248.61 through 2029. The $185.67 average target implies a +78% move from current prices. That is up +16% on the projected 2028 average. Momentum favours further upside here.
The CVS price prediction for 2030 points to an average of $201.63 (low $157.50, high $274.84) — a potential gain of +94% on today's $104.15. Buyers look set to stay in control over this stretch.
In 2031, CVS is projected to trade between $178.27 and $319.85, averaging $231.00 — a potential gain of +122% from today's $104.15. That is up +15% on the projected 2030 average. Momentum favours further upside here.
CVS Health Corporation's 2032 outlook centres on $292.64, within a $223.31 to $410.97 range. That is up +27% on the projected 2031 average. That marks a +181% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CVS could reach as high as $471.66, with a base case around $331.56 and support toward $250.38 — roughly +218% from $104.15. Momentum favours further upside here.
Expect CVS to range from $280.28 to $539.62 through 2034. The $374.86 average target implies a +260% move from current prices. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CVS price prediction for 2035 points to an average of $424.63 (low $314.52, high $618.08) — a potential gain of +308% on today's $104.15. Momentum favours further upside here.
In 2040, CVS is projected to trade between $508.27 and $1,091.72, averaging $715.71 — a potential gain of +587% from today's $104.15. That is up +69% on the projected 2035 average. Buyers look set to stay in control over this stretch.
CVS Health Corporation's 2050 outlook centres on $1,343.98, within a $889.93 to $2,197.52 range. That is up +88% on the projected 2040 average. That marks a +11.9x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CVS today (≈ 9.601536 CVS) could be worth
$12,904.32
+$11,904.32 (+1190%) by 2050 · US Dollar
Based on the average projected CVS price of $1,343.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CVSwould be worth at today's price.
$1,000 invested in CVS on Jul 10, 2025 (≈ 15.239256 CVS) would be worth
$1,587.17
+$587.17 (+58.7%) today · 1.59× · US Dollar
Based on a CVS entry price of $65.62 vs. today's $104.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $104.72 | $994.56 | -0.5% |
| 1 month ago | $98.02 | $1,062.54 | +6.3% |
| 3 months ago | $79.33 | $1,312.87 | +31.3% |
| 6 months ago | $80.36 | $1,296.04 | +29.6% |
| 1 year ago | $65.62 | $1,587.17 | +58.7% |
| All time (5.0y) ago | $82.42 | $1,263.65 | +26.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CVS forecast.
Our base-case forecast reaches $210.00 around 2031.
Implied market cap at $210.00: $267.94B
The multi-year forecast shows a bullish trajectory across key future years. In 2026, the average price is $100.48 with a 0 ROI. By 2027 the average rises to $139.65, with a 39 ROI, and by 2028 the average is $159.07, with a 58.3 ROI.
The 2030 forecast prints an average of $201.73 with a 100.8 ROI, supported by a min of $157.42 and a max of $275.36. By 2040 the average reaches $711.30 with a 607.9 ROI and a range of $504.81 to $1,085.73. In 2050 the average is $1,303.15 with a 1196.9 ROI and a range of $862.43 to $2,131.79, all labeled as BULLISH.
These projections imply substantial upside potential but remain estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $201.73, a min of $157.42, and a max of $275.36, with a 100.8 ROI and bullish sentiment.
Forecasts show bullish sentiment across multiple years beyond 2026, with rising average prices and positive ROI from 2027 onward, though forecasts are estimates and not guarantees.
Yes. The 2030 forecast lists a maximum of $275.36.
The current price is $100.48 and the market cap is $128.21B.
For 2040, the average forecast is $711.30, with a min of $504.81 and a max of $1,085.73, and an ROI of 607.9, with bullish sentiment.
CVS Health Corporation Community Discussion
0Share your CVS Health Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.